Even patients with such high-risk features as diabetes or renal compromise showed highly significant drops in CV mortality or heart-failure hospitalizations from treatment with eplerenone (Inspra, Pfizer) in EMPHASIS-HF.…
Read More »Yearly Archives: 2011
Possible Hope for Type 1’s
Patients with type 1 diabetes have been offered new hope as scientists test a drug that could save them from a lifetime of injections.…
Read More »Novel HDL-Raising Drug Appears Safe
A novel cholesteryl ester transfer protein (CETP) inhibitor, dalcetrapib, raised HDL cholesterol without any safety concerns in phase IIb dal-VESSEL trial, but it remains to be seen whether that boost in HDL will improve clinical outcomes….
Read More »Pharmacy Coaching Program Improves Diabetes and Hypertension
An innovative pharmacy coaching program from Anthem Blue Cross and Blue Shield in Ohio has helped a number of patients better manage diabetes and hypertension.…
Read More »Why Some People are Diabetic and Prone to Heart Disease
A team of researchers has discovered why some obese people develop chronic diseases such as diabetes and heart disease, and others do not.…
Read More »Editor’s Note: New Homerun Slides, Supplements for Neuropathy, and Patient Mistakes
Since we are coming up on our first year of bringing you our Diabetes Clinical Mastery Series, I spent some time looking over your reading trends and habits and found that the Homerun Slides are by far the most frequently visited destination. This week we are starting a new series …
Read More »Managing Clinical Problems in Diabetes, Case Study #19: Peripheral Neuropathy and Vitamin B
Edited by Trisha Dunning AM, RN, MEd, PhD, CDE, FRCNA and Glenn Ward MBBS, BSc, DPhil (Oxon), FRACP, FRCPath Mr. LOQ self-referred to a diabetes center. “I have a horrible burning feeling in my feet especially at night. I have had diabetes for a while and find it hard to …
Read More »Pathophysiology in the Treatment of Type 2 Diabetes: Newer Agents, Part 1 of 5
This week we begin a new five-part Homerun Slides series on Pathophysiology in the Treatment of Type 2 Diabetes focusing on Newer Agents, including Bromocriptine….
Read More »Letter from the Editor: Testing for a reason, it really works….
Two of the riders in this year’s US Pro Challenge on Sanofi’s Team Type 1 have type 1 diabetes and are doing quite well. To find out what happened in the stage 3 time trials see USA PRO CHALLENGE –Team Type 1 – Update. This week a family friend called …
Read More »USA PRO CHALLENGE –Team Type 1 – Update
Wednesday Fabio Calabria went down in an accident early in the race and was left with a bad road rash and bruising to his upper torso. But unlike his teammate Daniele Callegarin who ended up in the hospital for face and hand surgery he was able to get up …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.